These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 17911193)
1. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment. Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193 [TBL] [Abstract][Full Text] [Related]
2. Impact of rHuEPO therapy initiation on soluble adhesion molecule levels in haemodialysis patients. Kahraman S; Yilmaz R; Kirkpantur A; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C Nephrology (Carlton); 2005 Jun; 10(3):264-9. PubMed ID: 15958039 [TBL] [Abstract][Full Text] [Related]
3. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin]. Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321 [TBL] [Abstract][Full Text] [Related]
4. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3. Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544 [TBL] [Abstract][Full Text] [Related]
5. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326 [TBL] [Abstract][Full Text] [Related]
6. The effect of high-flux hemodialysis on renal anemia. Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038 [TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients. Khedr E; El-Sharkawy M; Abdulwahab S; Eldin EN; Ali M; Youssif A; Ahmed B Hemodial Int; 2009 Jul; 13(3):340-6. PubMed ID: 19552740 [TBL] [Abstract][Full Text] [Related]
8. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients]. Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis. Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100 [TBL] [Abstract][Full Text] [Related]
10. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease. Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549 [TBL] [Abstract][Full Text] [Related]
11. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients. Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889 [TBL] [Abstract][Full Text] [Related]
12. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients. Nakao K; Wada J; Ota K; Ichikawa H; Akagi S; Okamoto A; Hida K; Nagake Y; Makino H Am J Kidney Dis; 2003 Mar; 41(3):624-36. PubMed ID: 12612986 [TBL] [Abstract][Full Text] [Related]
13. [The effect of long term erythropoietin treatment on levels of free amino acids in patients with long term hemodialysis]. Boratyńska M; Boratyński J; Magott M; Szewczyk Z Przegl Lek; 1996; 53(5):398-401. PubMed ID: 8754400 [TBL] [Abstract][Full Text] [Related]
14. Complete correction of renal anemia by recombinant human erythropoietin. Ludat K; Paulitschke M; Riedel E; Hampl H Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805 [TBL] [Abstract][Full Text] [Related]
15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Li H; Wang SX Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498 [TBL] [Abstract][Full Text] [Related]
16. The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin. Tuzcu A; Bahceci M; Yilmaz E; Bahceci S; Tuzcu S Horm Metab Res; 2004 Oct; 36(10):716-20. PubMed ID: 15523598 [TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension in patients with chronic kidney insufficiency in hemodialysis with erythropoietin]. Martins Prata M; Teixeira de Sousa F; Barbas J; Vinhaś J; Marques da Costa A Rev Port Cardiol; 1990 Feb; 9(2):119-23. PubMed ID: 2346662 [TBL] [Abstract][Full Text] [Related]
18. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients. Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898 [TBL] [Abstract][Full Text] [Related]
19. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation. Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892 [TBL] [Abstract][Full Text] [Related]
20. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance. Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY; J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]